ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

NTP Release Third Report On Carcinogens

January 13, 1984

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

July 18, 1980

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005